Ibm Retirement Fund Moderna, Inc. Transaction History

Ibm Retirement Fund

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$117.13 - $176.59 $632,502 - $953,586	-5,400 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$126.46 - $235.05 $29,718 - $55,236	-235 Reduced 4.17%	5,400 $930,000
Q4 2021 Jan 19, 2022	SELL	$225.82 - $368.51 $888,827 - $1.45 Million	-3,936 Reduced 41.12%	5,635 $1.43 Million
Q3 2021 Oct 05, 2021	BUY	$221.9 - $484.47 $4,881 - $10,658	22 Added 0.23%	9,571 $3.68 Million
Q2 2021 Jul 12, 2021	SELL	$129.91 - $234.98 $23,643 - $42,766	-182 Reduced 1.87%	9,549 $2.24 Million
Q1 2021 Apr 22, 2021	SELL	$109.18 - $185.98 $93,239 - $158,826	-854 Reduced 8.07%	9,731 $1.27 Million
Q4 2020 Jan 25, 2021	BUY	$65.74 - $169.86 $85,987 - $222,176	1,308 Added 14.1%	10,585 $1.11 Million
Q3 2020 Oct 16, 2020	BUY	$54.34 - $94.85 $162,965 - $284,455	2,999 Added 47.77%	9,277 $656,000
Q2 2020 Jul 08, 2020	BUY	$29.67 - $80.0 $186,268 - $502,240	6,278 New	6,278 $403,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Ibm Retirement Fund with notifications on news.